Emerging Mumps Infection.

M is one of the older described infectious diseases, first documented by Hippocrates in the fifth century BC. Before widespread use of mumps vaccines, mumps was a common disease of childhood, with nearly everyone having serologic evidence of prior infection by age 15. The virus is spread by direct contact with respiratory droplets. Salivary gland swelling, usually the parotid, is the most common physical manifestation; however, mumps virus, a paramyxovirus, can disseminate widely throughout the body, including the central nervous system, causing a wide array of medical presentations. For example, in the pre-vaccine era, mumps was the leading cause of viral encephalitis and sudden onset deafness in the United States.

[1]  E. Belongia,et al.  Mumps Antibody Response in Young Adults After a Third Dose of Measles-Mumps-Rubella Vaccine , 2014, Open forum infectious diseases.

[2]  R. Bremel,et al.  Are cases of mumps in vaccinated patients attributable to mismatches in both vaccine T-cell and B-cell epitopes? , 2013, Human vaccines & immunotherapeutics.

[3]  A. Oberg,et al.  Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century. , 2013, Seminars in immunology.

[4]  W. Bellini,et al.  Epidemiology of a Mumps Outbreak in a Highly Vaccinated Island Population and Use of a Third Dose of Measles–Mumps–Rubella Vaccine for Outbreak Control—Guam 2009 to 2010 , 2013, The Pediatric infectious disease journal.

[5]  W. Bellini,et al.  Comparison of the Sensitivity of Laboratory Diagnostic Methods from a Well-Characterized Outbreak of Mumps in New York City in 2009 , 2013, Clinical and Vaccine Immunology.

[6]  I. Ogbuanu,et al.  Impact of a Third Dose of Measles-Mumps-Rubella Vaccine on a Mumps Outbreak , 2012, Pediatrics.

[7]  M. Paunio,et al.  Waning antibody levels and avidity: implications for MMR vaccine-induced protection. , 2012, The Journal of infectious diseases.

[8]  S. Rubin,et al.  Recent Mumps Outbreaks in Vaccinated Populations: No Evidence of Immune Escape , 2011, Journal of Virology.

[9]  W. Bellini,et al.  Enzyme-Linked Immunospot Assay Detection of Mumps-Specific Antibody-Secreting B Cells as an Alternative Method of Laboratory Diagnosis , 2010, Clinical and Vaccine Immunology.

[10]  A. Curns,et al.  Mumps vaccine performance among university students during a mumps outbreak. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  M. Hilleman,et al.  Live, attenuated mumps-virus vaccine. , 1968, The New England journal of medicine.

[12]  M. Hilleman,et al.  Live attenuated mumps-virus vaccine. 3. Clinical and serologic aspects in a field evaluation. , 1967, The New England journal of medicine.